DGH
DEAD

Serial Number

98273074

Owner

KromaTiD Inc.

Attorney

Amanda H. Wilcox

First Use Date

Jun 27, 2007

Filing Date

Nov 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DGH Trademark

Serial Number: 98273074

DGH is a trademark filed by KromaTiD Inc. on November 16, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

KromaTiD Inc. (13 trademarks)

1880 INDUSTRIAL CIRCLE DRIVE SUITE A
LONGMONT, CO 80501

Entity Type: 03

Trademark Details

Filing Date

November 16, 2023

Registration Date

Not Registered

First Use Anywhere

June 27, 2007

First Use in Commerce

June 27, 2007

Goods & Services

Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Cells for medical use; Clinical medical reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Culture media for cultivating human blood cells; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes

DNA screening for medical purposes

Custom design and development of chemical reagents and biochemical assays; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research in the field of oncology; Medical research services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Genetic testing for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 8, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 8, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2023 NWOS
NEW APPLICATION ENTERED
Nov 20, 2023 NWAP